R Schade

2.1k total citations · 1 hit paper
23 papers, 1.5k citations indexed

About

R Schade is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, R Schade has authored 23 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in R Schade's work include Inflammatory mediators and NSAID effects (11 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Gastroesophageal reflux and treatments (3 papers). R Schade is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Gastroesophageal reflux and treatments (3 papers). R Schade collaborates with scholars based in Germany, Netherlands and Italy. R Schade's co-authors include Edeltraut Garbe, Frank Andersohn, Samy Suissa, Wilhelm Haverkamp, Miriam Sturkenboom, Vera E. Valkhoff, Stefan N. Willich, Ron M. C. Herings, Martijn J. Schuemie and Tania Schink and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and PLoS ONE.

In The Last Decade

R Schade

23 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation

2007 490 citations R Schade, Frank Andersohn et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by R Schade

Since Specialization

Citations

This map shows the geographic impact of R Schade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Schade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Schade more than expected).

Fields of papers citing papers by R Schade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Schade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Schade. The network helps show where R Schade may publish in the future.

Co-authorship network of co-authors of R Schade

This figure shows the co-authorship network connecting the top 25 collaborators of R Schade. A scholar is included among the top collaborators of R Schade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Schade. R Schade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Value of Federated Data Networks in Oncology: What Research Questions Do They Answer? Outcomes From a Systematic Literature Review 2021 ·Value in Health ·Matthias Hünger, Kristina Bardenheuer, (unknown), R Schade, Ruchika Sharma, (unknown)	3
2	Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project 2018 ·PLoS ONE ·Gwen Masclee, Huub Straatman, Andrea Arfè, Jordi Castellsagué, Edeltraut Garbe, Ron M. C. Herings, Bianca Kollhorst, S Lucchi, Susana Perez‐Gutthann, Silvana Romio, R Schade, Tania Schink, Martijn J. Schuemie, Lorenza Scotti, Cristina Varas‐Lorenzo, Vera E. Valkhoff, Marco Villa, Miriam Sturkenboom	44
3	Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study 2016 ·BMJ ·Andrea Arfè, Lorenza Scotti, Cristina Varas‐Lorenzo, Federica Nicotra, Antonella Zambon, Bianca Kollhorst, Tania Schink, Edeltraut Garbe, Ron M. C. Herings, Huub Straatman, R Schade, Marco Villa, S Lucchi, Vera E. Valkhoff, Silvana Romio, Frantz Thiessard, Martijn J. Schuemie, Alexandre Pariente, Miriam Sturkenboom, Giovanni Corrao	197
4	P1259 : Hepatitis B in pregnancy in Ukraine: Wasted chance 2015 ·Journal of Hepatology ·(unknown), (unknown), R Schade, (unknown)	2
5	Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues? 2013 ·BMC Pediatrics ·Vera E. Valkhoff, R Schade, Geert W. ‘t Jong, Silvana Romio, Martijn J. Schuemie, Andrea Arfè, Edeltraut Garbe, Ron M. C. Herings, S Lucchi, Gino Picelli, Tania Schink, Huub Straatman, Marco Villa, Ernst J. Kuipers, Miriam Sturkenboom	29
6	Cyclo‐oxygenase‐2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? 2013 ·Alimentary Pharmacology & Therapeutics ·Gwen Masclee, Vera E. Valkhoff, Eva M. van Soest, R Schade, Giampiero Mazzaglia, Mariam Molokhia, Gianluca Trifirò, Jay L. Goldstein, Sonia Hernández–Dı́az, Ernst J. Kuipers, Miriam Sturkenboom	11
7	1038 Cyclo-Oxygenase-2 Inhibitors or Nonselective NSAIDs Plus Gastroprotective Agents: What to Prescribe in Daily Clinical Practice? 2013 ·Gastroenterology ·Gwen Masclee, Vera E. Valkhoff, Eva M. van Soest, R Schade, Giampiero Mazzaglia, Mariam Molokhia, Gianluca Trifirò, Jay L. Goldstein, Sonia Hernández–Dı́az, Ernst J. Kuipers, Miriam Sturkenboom	2
8	Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project. 2012 ·Pharmacoepidemiology and Drug Safety ·S Lucchi, (unknown), Bianca Kollhorst, Tania Schink, Edeltraut Garbe, Andrea Arfè, Jordi Castellsagué, RM Herings, (unknown), Silvana Romio, Francesco Salvo, R Schade, (unknown), Huub Straatman, Frantz Thiessard, Miriam Sturkenboom, Marco Villa	2
9	Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population‐based study 2012 ·Arthritis & Rheumatism ·Vera E. Valkhoff, Eva M. van Soest, Giampiero Mazzaglia, Mariam Molokhia, R Schade, Gianluca Trifirò, Jay L. Goldstein, Sonia Hernández–Dı́az, Ernst J. Kuipers, Miriam Sturkenboom	13
10	Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases 2011 ·Gut ·Eva M. van Soest, Vera E. Valkhoff, Giampiero Mazzaglia, R Schade, Mariam Molokhia, Jay L. Goldstein, Sonia Hernández–Dı́az, Gianluca Trifirò, (unknown), Ernst J. Kuipers, Miriam Sturkenboom	55
11	Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinsonʼs Disease and Hyperprolactinaemia 2011 ·Drug Safety ·Gianluca Trifirò, Mostafa M. Mokhles, Jeanne P. Dieleman, Eva M. van Soest, Katia Verhamme, Giampiero Mazzaglia, Ron M. C. Herings, Cynthia de Luise, Douglas A. Ross, Guy Brusselle, Annamaria Colao, Wilhelm Haverkamp, R Schade, Guy Van Camp, R Zanettini, Miriam Sturkenboom	36
12	The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease 2011 ·Pharmacological Research ·(unknown), Gianluca Trifirò, Jeanne P. Dieleman, Mendel Haag, Eva M. van Soest, Katia Verhamme, Giampiero Mazzaglia, Ron M. C. Herings, Cynthia de Luise, Douglas A. Ross, Guy Brusselle, Annamaria Colao, (unknown), R Schade, Guy Van Camp, R Zanettini, Miriam Sturkenboom	46
13	Time-Trends in Use of Gastroprotective Strategies With NSAID Treatment in the United Kingdom, Italy, and the Netherlands; A Comparative Study 2011 ·Gastroenterology ·Vera E. Valkhoff, Eva M. van Soest, Jeanne P. Dieleman, R Schade, Giampiero Mazzaglia, Mariam Molokhia, Ernst J. Kuipers, Miriam Sturkenboom	1
14	Adherence to Gastroprotective Agents and the Risk of Upper Gastrointestinal Complications in Coxib Users 2011 ·Gastroenterology ·Vera E. Valkhoff, Eva M. van Soest, Giampiero Mazzaglia, R Schade, Mariam Molokhia, Jay L. Goldstein, Sonia Hernández–Dı́az, Gianluca Trifirò, Jeanne P. Dieleman, Ernst J. Kuipers, Miriam Sturkenboom	1
15	Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior 2010 ·Neurology ·Frank Andersohn, R Schade, Stefan N. Willich, Edeltraut Garbe	96
16	Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus 2009 ·American Journal of Psychiatry ·Frank Andersohn, R Schade, Samy Suissa, Edeltraut Garbe	212
17	Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation breakdown → 2007 ·New England Journal of Medicine ·R Schade, Frank Andersohn, Samy Suissa, Wilhelm Haverkamp, Edeltraut Garbe	490
18	Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation 2007 ·Obstetrical & Gynecological Survey ·R Schade, Frank Andersohn, Samy Suissa, Wilhelm Haverkamp, Edeltraut Garbe	5
19	Integrating temporal media and open hypermedia on the World Wide Web 1999 ·Computer Networks ·Niels Olof Bouvin, R Schade	14
20	A controlled comparison of continuous intraarterial and intravenous infusions of vasopressin in hemorrhage from esophageal varices 1979 ·Gastroenterology ·Mario Chojkier, Roberto J. Groszmann, Colin E. Atterbury, Simon Bar–Meir, Andrés T. Blei, J P Frankel, Morton G. Glickman, (unknown), R Schade, (unknown), Harold O. Conn	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact